永久资源定位符：中性鱼精蛋白锌胰岛素：它仍然是个不错的选择。
PURL: NPH insulin: It remains a good option.
作者信息
Arthur Ben, Smith Ashley, Bennett Nick, Bury David, Marshall Bob
机构信息
Madigan Family Medicine Residency, JBLM/Tacoma, WA, USA.
出版信息
J Fam Pract. 2020 Mar;69(2):94-95.
Abstract
NPH insulin holds its own against basal insulin analogs-and it's cheaper.
摘要
中性鱼精蛋白锌胰岛素与基础胰岛素类似物效果相当，而且价格更便宜。
相似文献
1
PURL: NPH insulin: It remains a good option.永久资源定位符：中性鱼精蛋白锌胰岛素：它仍然是个不错的选择。
J Fam Pract. 2020 Mar;69(2):94-95.
2
Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.基础胰岛素类似物与中性鱼精蛋白胰岛素起始治疗与 2 型糖尿病患者低血糖相关急诊就诊或住院及血糖控制的关系。
JAMA. 2018 Jul 3;320(1):53-62. doi: 10.1001/jama.2018.7993.
3
Hypoglycemia with insulin in post-transplant diabetes mellitus.移植后糖尿病伴胰岛素所致低血糖症
Transpl Immunol. 2023 Jun;78:101833. doi: 10.1016/j.trim.2023.101833. Epub 2023 Apr 5.
4
Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.与睡前中性鱼精蛋白锌胰岛素相比，在2型糖尿病胰岛素联合治疗中，使用甘精胰岛素睡前注射可减少夜间低血糖发生，并改善晚餐后血糖控制。HOE 901/3002研究组。
Diabetes Care. 2000 Aug;23(8):1130-6. doi: 10.2337/diacare.23.8.1130.
5
Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.在11项关于甘精胰岛素与中性鱼精蛋白锌胰岛素治疗1型和2型糖尿病的III期和IV期研究中，对糖化血红蛋白和低血糖结局合并数据进行的负二项式meta回归分析。
Clin Ther. 2007 Aug;29(8):1607-19. doi: 10.1016/j.clinthera.2007.08.020.
6
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.将1型糖尿病且有严重低血糖病史患者的基础胰岛素从NPH改为地特胰岛素或甘精胰岛素。
Vasc Health Risk Manag. 2009;5(1):121-8. Epub 2009 Apr 8.
7
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.甘精胰岛素降低低血糖风险：一项比较甘精胰岛素与中性鱼精蛋白锌人胰岛素治疗2型糖尿病的荟萃分析
Diabetes Care. 2005 Apr;28(4):950-5. doi: 10.2337/diacare.28.4.950.
8
A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).一项使用持续血糖监测评估低血糖发生率的随机试验，比较了 125 例接受甘精胰岛素或 NPH 胰岛素治疗的 1 型糖尿病学龄前儿童（PRESCHOOL 研究）。
Pediatr Diabetes. 2013 Dec;14(8):593-601. doi: 10.1111/pedi.12051. Epub 2013 Jun 3.
9
Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.使用基础-餐时胰岛素治疗方案时，地特胰岛素或中性鱼精蛋白锌胰岛素对1型糖尿病患者血糖控制的影响。
Clin Ther. 2004 May;26(5):724-36. doi: 10.1016/s0149-2918(04)90072-0.
10
Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.在采用餐时门冬胰岛素的基础-餐时胰岛素治疗方案的1型糖尿病患者中，与NPH胰岛素相比，地特胰岛素与更可预测的血糖控制及更低的低血糖风险相关。
Diabetes Care. 2003 Mar;26(3):590-6. doi: 10.2337/diacare.26.3.590.
引用本文的文献
1
Higher Order Structure Differences Among Insulin Crystalline Drugs Revealed by 2D heteronuclear NMR.二维异核核磁共振揭示胰岛素结晶药物的高阶结构差异
ChemMedChem. 2024 Dec 2;19(23):e202400340. doi: 10.1002/cmdc.202400340. Epub 2024 Sep 30.
2
Current State and Principles of Basal Insulin Therapy in Type 2 Diabetes.2型糖尿病基础胰岛素治疗的现状与原则
J Clin Med Res. 2022 Jan;14(1):8-21. doi: 10.14740/jocmr4660. Epub 2022 Jan 29.
本文引用的文献
1
Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299-1311.勘误。胰岛素可及性与可负担性工作组：结论与建议。《糖尿病护理》2018年；41卷；1299 - 1311页。
Diabetes Care. 2018 Aug;41(8):1831. doi: 10.2337/dc18-er08. Epub 2018 Jun 28.
2
Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.基础胰岛素类似物与中性鱼精蛋白胰岛素起始治疗与 2 型糖尿病患者低血糖相关急诊就诊或住院及血糖控制的关系。
JAMA. 2018 Jul 3;320(1):53-62. doi: 10.1001/jama.2018.7993.
3
Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.2017 年美国糖尿病协会糖尿病医疗护理标准中的 2 型糖尿病药物治疗：概要。
Ann Intern Med. 2017 Apr 18;166(8):572-578. doi: 10.7326/M16-2937. Epub 2017 Mar 14.
4
Long-term outcomes of analogue insulin compared with NPH for patients with type 2 diabetes mellitus.2型糖尿病患者使用类似物胰岛素与中性鱼精蛋白锌胰岛素的长期疗效比较。
Am J Manag Care. 2015 Mar 1;21(3):e235-43.
5
Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012.1997 - 2012年美国2型糖尿病的门诊治疗
Diabetes Care. 2014 Apr;37(4):985-92. doi: 10.2337/dc13-2097. Epub 2013 Nov 6.
6
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.长效胰岛素类似物与NPH胰岛素（人低精蛋白胰岛素）治疗2型糖尿病的比较
Cochrane Database Syst Rev. 2007 Apr 18(2):CD005613. doi: 10.1002/14651858.CD005613.pub3.
Zotero 插件